Mikael K. Poulsen - Publications

Low-dose, short-duration catheter-directed thrombolysis for acute intermediate-high-risk pulmonary embolism: the BETULA trial.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology

Published: August 18, 2026

Targeted left ventricular lead placement in biventricular pacing for heart failure: a national, multicentre, double-blind, randomised controlled trial in Denmark.

Journal: Lancet (London, England)

Published: July 14, 2026

Pan-enteric Video Capsule Endoscopy in Hereditary Haemorrhagic Telangiectasia: Gastrointestinal Manifestations and Feasibility.

Journal: Endoscopy international open

Published: March 06, 2026

Invasive Hemodynamic Exercise Response in Hemodynamically Significant Aortic Stenosis With Preserved Left Ventricular Ejection Fraction.

Journal: Circulation. Heart failure

Published: February 23, 2026

Invasive Hemodynamic Exercise Response in Hemodynamically Significant Aortic Stenosis With Preserved Left Ventricular Ejection Fraction.

Journal: Circulation. Heart failure

Published: February 23, 2026

Haemodynamic alterations associated with hepatic vascular malformations in hereditary haemorrhagic telangiectasia: A cohort study.

Journal: JHEP reports : innovation in hepatology

Published: November 30, 2025

Empagliflozin and functional aerobic capacity in individuals with increased risk of heart failure: The Empire Prevent Cardiac trial.

Journal: American heart journal

Published: October 09, 2025

The Effect of Empagliflozin on Left Ventricular Mass and Volumes in Older Adult Individuals With Overweight and High Risk of Heart Failure: The Empire Prevent Cardiac Trial.

Journal: Journal of cardiac failure

Published: September 26, 2025

Effects of empagliflozin on right ventricular free-wall strain in patients with heart failure and reduced ejection fraction: results from the Empire HF Trial.

Journal: ESC heart failure

Published: July 29, 2025

Effects of Empagliflozin on Right Ventricular Function in Heart Failure with Reduced Ejection Fraction.

Journal: medRxiv : the preprint server for health sciences

Published: June 12, 2025

Should Exogenous Ketone Body Supplementation Be Considered in Patients Hospitalized for Acute Heart Failure? Rationale and Design of the KETO-AHF Trial.

Journal: Journal of cardiac failure

Published: February 11, 2025

Accelerometer-measured physical activity in patients with heart failure and reduced ejection fraction: Determinants and relationship with patient-reported health status.

Journal: American heart journal

Published: April 11, 2024